A groundbreaking clinical trial is bringing renewed hope to children with an incurable form of paediatric brain cancer.
The FIREFLY-1 trial tested the efficacy of oral drug, tovorafenib, in patients with BRAF-altered (a genetic mutation), relapsed or progressive paediatric low-grade glioma (pLGG), with results showing... read more.
You are viewing this article on the Sydney Children's Hospitals Network website. To see read the full article, please see the Kids Research website.
Read full article